SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Br J Sports Med. 2021;55(18):1034-1040.

Association of physical activity with all-cause and cardiovascular mortality in 7666 adults with hypertrophic cardiomyopathy (HCM): more physical activity is better.

, , , , , , , , , , , , , ,

제1저자 권순일, 이현정 · 교신저자 김형관, Steve R. Ommen

소속 (5)
  1. Department of Cardiology, Seoul National University Hospital, Seoul, Republic of Korea.
  2. Department of Biostatistics, Catholic University College of Medicine, Seoul, Republic of Korea.
  3. Department of Cardiology, Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  4. Department of Cardiology, Seoul National University Hospital, Seoul, Republic of Korea cardiman73@gmail.com ommen.steve@mayo.edu.
  5. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA cardiman73@gmail.com ommen.steve@mayo.edu.

Abstract

OBJECTIVES Recommendations on physical activity (PA) for adults with hypertrophic cardiomyopathy (HCM) are not well established. We investigated the association of PA intensity with mortality in the general adult HCM population.

METHODS A nationwide population-based cohort of individuals with HCM who underwent health check-ups including questionnaires on PA levels were identified from the years 2009 to 2016 in the National Health Insurance Service database. Subjects who reported no PA at baseline were excluded. To estimate each individual's PA level, the PA score (PAS) was calculated based on the self-reported questionnaires, and the study population was categorised into three groups according to tertiles of PAS. The associations of PAS with all-cause and cardiovascular mortality were analysed.

RESULTS A total of 7666 participants (mean age 59.5 years, 29.9% were women) were followed up for a mean 5.3±2.0 years. All-cause and cardiovascular mortality progressively decreased from the lowest to the highest tertiles of PA intensity: 9.1% (4.7%), 8.9% (3.8%) and 6.4% (2.7%), respectively (p-for-trend=0.0144 and 0.0023, respectively). Of note, compared with the middle PA group, the highest PA group did not have an increased risk of all-cause and cardiovascular mortality (HR 0.78, (95% CI 0.63 to 0.95) and HR 0.75 (95% CI 0.54 to 1.03), respectively). All subgroup and sensitivity analyses consistently showed that all-cause and cardiovascular mortality did not increase with higher PA levels.

CONCLUSIONS Moderate-to-vigorous-intensity PA, in a middle-aged population of patients with HCM, was associated with progressive reduction of all-cause and cardiovascular mortality. The impact of vigorous-intensity PA on a younger age group requires further investigation.

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Keywords

cardiologydeathphysical activity

Conflict of interest statement

Competing interests: H-KK reports research grants from Actelion, Handok Pharmaceuticals, Dae-Woong Pharmaceuticals, Yuhan, Hanmi, ChongKunDang Pharmaceuticals, and Norvatis.

그 밖의 정보
출판 형태
Journal Article
저널
British journal of sports medicine · eISSN 1473-0480
전자 출판
2020-09-23
MeSH
Adult · Cardiomyopathy, Hypertrophic* / mortality · Cohort Studies · Exercise* · Female · Humans · Male · Middle Aged · Mortality · Risk Factors · Self Report · Surveys and Questionnaires